You are here: Industry Insights > fast track designation

News List

Novavax COVID-19 vaccine granted Fast Track Designation by U.S. FDA worldpharmanews
November 11, 2020
Novavax, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for NVX-CoV2373, the Company’s COVID-19 vaccine candidate.
Biohaven's Verdiperstat Receives Fast Track Designation for Multiple System Atrophy Treatment americanpharmaceuticalreview
March 19, 2020
Biohaven Pharmaceutical announced the Company's myeloperoxidase (MPO) inhibitor, verdiperstat, received Fast Track designation from the US Food and Drug Administration (FDA) ...
FDA Grants Fast Track Designation for Heart Failure Treatment americanpharmaceuticalreview
January 17, 2020
Arena Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) granted Fast Track designation for APD418, a β3-adrenergic receptor (AdrR) antagonist and cardiac myotrope, in development for the treatment of decompensated heart failure (DHF).
Moderna Receives FDA Fast Track Designation for Zika Vaccine biospectrumasia
August 21, 2019
Investigational Zika vaccine (mRNA-1893) is currently being evaluated in a Phase 1 study for the prevention of Zika virus infection in healthy adults
uniQure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease firstwordpharma
April 10, 2019
The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs to treat serious ……
HighTide Therapeutics Receives Fast Track Designation for HTD1801 americanpharmaceuticalreview
September 29, 2018
HighTide Therapeutics announced the FDA has granted Fast Track Designation to its investigational new drug, HTD1801, for the treatment of patients with primary sclerosing cholangitis (PSC).
FDA grants fast track designation for a Chikungunya vaccine europeanpharmaceuticalreview
May 15, 2018
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs…